Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3450
+0.0050 (1.47%)
Oct 16, 2026, 4:10 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 102.15 million as of October 16, 2026. It is the 27,725th most valuable company in the world and the 613th biggest in Australia. Its market cap has increased by 8.79% in one year.
Market Cap
102.15M
Enterprise Value
89.28M
Revenue
282.66K
Global Rank
Country Rank
#613 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 102.15M, an increase of 140.31%. That is a compound annual growth rate of 17.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 102.15M | -11.70% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 165.46M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 126.08M |
| Nyrada | 106.46M |
| Recce Pharmaceuticals | 85.62M |
| LTR Pharma | 80.20M |
| Alterity Therapeutics | 71.02M |
| Prescient Therapeutics | 69.77M |